18 results
8-K
EX-99.1
ARVN
Arvinas Inc
5 May 23
Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:30am
neurons, while sparing wild-type HTT.
Appointed Kelly Page as Senior Vice President, Global Head of Oncology Strategy and Program Leadership
8-K
EX-99.1
ARVN
Arvinas Inc
16 Dec 22
Arvinas Announces Changes to its Board of Directors
9:02am
Executive Officer at Arvinas. “We will miss him and his inspiring leadership, and we wish him the best of luck in his future endeavors.”
Mr. Cunningham … joins Arvinas’ Board with over 25 years of experience in pharmaceuticals and medical services and a commitment to leadership excellence. He currently
8-K
EX-99.1
7e504wt
3 Nov 21
Arvinas Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:01pm
8-K
EX-99.1
ppw9df3i
5 Aug 21
Arvinas Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-99.1
ml168pr
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-99.1
d8us6zv8rm6ft
4 May 21
Arvinas Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-99.2
ye5dgyp72zi2
23 Oct 19
Arvinas Presents a Platform Update, Including Initial Data from the First Two Clinical Trials of PROTAC® Targeted Protein Degraders
6:39am
8-K
EX-99.1
m6u37yv
5 Aug 19
Arvinas Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:05pm
DEF 14A
zdm967z r4f
12 Apr 19
Definitive proxy
5:02pm
DRS/A
lpt7rqtsggff
2 Aug 18
Draft registration statement (amended)
12:00am
DRS
n59q gdbi
22 Jun 18
Draft registration statement
12:00am
- Prev
- 1
- Next